Search Browse Earnings

Syndax Pharmaceuticals Inc — SlamSEC

Syndax Pharmaceuticals Inc

Nasdaq:SNDX

Pharmaceutical Preparations·NEW YORK, NY

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$0

FY 2025

Adj. EBITDA

-$222.0M

FY 2025

Net Income

-$209.4M

FY 2025

EPS (Diluted)

-$2.98

FY 2025

Stock Price

$23.87

+8.1%

2026-03-09

52W Range

$8.58 – $24.84

P/E Ratio

-8.0x

Market Cap

$2.1B

Cash

$295.4M

FY 2025

Total Debt

$343.7M

FY 2024

Net Debt

$48.3M

FY 2024

Enterprise Value

$2.2B

Debt / EBITDA

-0.2x

FY 2025

EV / EBITDA

-9.7x

Employees

—